📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
4 articles
AVG GRADE
NEUTRAL
score: 0.25
SENTIMENT
BULLISH
TOTAL VIEWS
9
IOVA Latest News & AI Sentiment Analysis
4 articles · Grade: NEUTRAL · Real-time AI-graded coverage
RECENT COVERAGE · 5 ARTICLES
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance Biotherapeutics announced routine inducement grants totaling 139,930 stock options to seventeen newly hired non-executive...
Top Biotech Gainers: APLM Climbs 22%; IOVA, RCEL On Watch; MANE Gains On Hair Loss Data
APLM's 22% gain reflects a technical relief rally following Nasdaq compliance restoration rather than fundamental clinical advancement....
12 Best Penny Stocks to Invest In According to Billionaires
This article presents a curated list of penny stocks purportedly favored by billionaire investors, anchored by the observation that the...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance Biotherapeutics announced routine inducement equity grants to 27 new non-executive employees totaling 140,860 stock options on...
Iovance Biotherapeutics: Commercial, Clinical And Regulatory Tailwinds (NASDAQ:IOVA)
Iovance Biotherapeutics (IOVA) issued forward guidance projecting $350–$370M in 2026 revenue, representing 36% year-over-year growth....
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice